Literature DB >> 17915616

Oxidative status and prevalent cardiovascular disease in patients with chronic renal failure treated by hemodialysis.

M Dirican1, E Sarandol, Z Serdar, N Ocak, K Dilek.   

Abstract

BACKGROUND: Hemodialysis (HD) patients are exposed to oxidative stress which contributes to cardiovascular disease (CVD). The purpose of this study was to investigate the oxidative and antioxidative status in HD patients with (CVD+, n = 38) and without (CVD-, n = 67) prevalent CVD. PATIENTS AND METHODS: A total of 105 HD patients and 21 healthy controls were assessed for lipid peroxidation indices (plasma malondialdehyde (MDA)), oxidizability of apolipoprotein B-containing lipoproteins (apo B-deltaMDA) and red blood cells (RBC-MDA) together with various components of the antioxidant system in plasma (paraoxonase/arylesterase activities, total carotenoids, vitamins C and E) and RBC (superoxide dismutase and glutathione peroxidase activities).
RESULTS: Plasma MDA and RBC-MDA were significantly higher, vitamin C and total carotenoid levels were significantly lower in both CVD+ and CVD- HD groups than in the control group. Plasma MDA levels were significantly higher and serum paraoxonase activity, uric acid and albumin levels were significantly lower in patients with CVD+ HD patients compared to those of the CVD- patients.
CONCLUSION: This study suggests that the elevated level of plasma MDA and the lower activity of paraoxonase could contribute to the increased incidence of cardiovascular disease in hemodialysis patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17915616     DOI: 10.5414/cnp68144

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  9 in total

Review 1.  Paraoxonase 1, atherosclerosis and arterial stiffness in renal patients.

Authors:  Ozkan Gungor; Fatih Kircelli; Huseyin Toz
Journal:  Int Urol Nephrol       Date:  2012-06-06       Impact factor: 2.370

2.  Effect of febuxostat on oxidative stress in hemodialysis patients with endothelial dysfunction: a randomized, placebo-controlled, double-blinded study.

Authors:  Mona Alshahawey; Sara M Shaheen; Tamer Elsaid; Nagwa Ali Sabri
Journal:  Int Urol Nephrol       Date:  2019-08-01       Impact factor: 2.370

3.  Effect of hemodialysis and peritoneal dialysis on redox status in chronic renal failure patients: a comparative study.

Authors:  Khedidja Mekki; Warda Taleb; Nassima Bouzidi; Abbou Kaddous; Malika Bouchenak
Journal:  Lipids Health Dis       Date:  2010-09-03       Impact factor: 3.876

4.  Effect of different stages of chronic kidney disease and renal replacement therapies on oxidant-antioxidant balance in uremic patients.

Authors:  Hadja Fatima Tbahriti; Abbou Kaddous; Malika Bouchenak; Khedidja Mekki
Journal:  Biochem Res Int       Date:  2013-12-12

Review 5.  Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins.

Authors:  Nans Florens; Catherine Calzada; Egor Lyasko; Laurent Juillard; Christophe O Soulage
Journal:  Toxins (Basel)       Date:  2016-12-16       Impact factor: 4.546

6.  Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients.

Authors:  Alicja E Grzegorzewska; Paulina Adamska; Ewa Iwańczyk-Skalska; Kamila Ostromecka; Leszek Niepolski; Wojciech Marcinkowski; Adrianna Mostowska; Wojciech Warchoł; Czesław Żaba; Paweł P Jagodziński
Journal:  Sci Rep       Date:  2021-03-24       Impact factor: 4.379

7.  Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.

Authors:  María Jesús Izquierdo; Mónica Cavia; Pilar Muñiz; Angel L M de Francisco; Manuel Arias; Javier Santos; Pedro Abaigar
Journal:  BMC Nephrol       Date:  2012-11-27       Impact factor: 2.388

8.  Effect of Oxidative Stress in Hemodialysed Patients.

Authors:  Attila Peti; Botond Csiky; Eszter Guth; Peter Kenyeres; Emese Mezosi; Gabor L Kovacs; Laszlo Bajnok
Journal:  EJIFCC       Date:  2011-07-20

Review 9.  Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden?

Authors:  Anila Duni; Vassilios Liakopoulos; Karolos-Pavlos Rapsomanikis; Evangelia Dounousi
Journal:  Oxid Med Cell Longev       Date:  2017-11-23       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.